ACLARION, INC. Share-based Payment Arrangement, Expense
ACLARION, INC. (ACON) reported Share-based Payment Arrangement, Expense of $12.13 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06
- ACLARION, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $12.13K, a 57.24% decline year-over-year.
- ACLARION, INC. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $28.36K.
- ACLARION, INC. share-based payment arrangement, expense for the quarter ending 2022-06-30 was $701.50K, a 14724.70% increase year-over-year.
- ACLARION, INC. share-based payment arrangement, expense for the quarter ending 2021-06-30 was $4.73K.
- ACLARION, INC. share-based payment arrangement, expense for fiscal 2022 was $102.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|
| 2026-06-30 | $12.13K 10-Q · filed 2026-08-06 | $16.82K 10-Q · filed 2026-08-06 | |
| 2025-06-30 | $28.36K 10-Q · filed 2026-08-06 | $84.26K 10-Q · filed 2026-08-06 | |
| 2022-12-31 | $102.00K 10-K/A · filed 2023-06-12 | ||
| 2022-06-30 | $701.50K 10-Q · filed 2022-08-15 | $724.63K 10-Q · filed 2022-08-15 | |
| 2021-06-30 | $4.73K 10-Q · filed 2022-08-15 | $9.46K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |